Insider Trading April 24, 2026 04:59 PM

Sonoco CFO Executes Significant Open Market Stock Purchase Amid Recent Price Volatility

Paul Joachimczyk increases direct ownership in Sonoco Products Co following a 14.3% weekly decline in share price.

By Derek Hwang SON
Sonoco CFO Executes Significant Open Market Stock Purchase Amid Recent Price Volatility
SON

Paul Joachimczyk, the Chief Financial Officer of Sonoco Products Co (NASDAQ: SON), has executed a notable purchase of company common stock. According to a Form 4 filing submitted to the Securities and Exchange Commission, the transaction occurred on April 24, 2026. The acquisition took place during a period of recent downward pressure on the stock price, which saw a decline of 14.3% over the preceding week. Mr. Joachimczyk acquired 8,058 shares at an individual share price of $49.64, representing a total investment of approximately $399,998. Following this transaction, his direct holdings in the company's common stock have risen to 28,558 shares.

Key Points

  • CFO Paul Joachimczyk purchased 8,058 shares at $49.64 per share, totaling nearly $400,000.
  • The transaction occurred after a 14.3% decline in stock price over one week.
  • BofA Securities maintains a Buy rating despite lowering the price target to $65.

In a significant move of internal confidence, Sonoco Products Co CFO Paul Joachimczyk has increased his personal stake in the firm through an open market transaction. On April 24, 2026, Mr. Joachimczyk purchased 8,058 shares of common stock at a price of $49.64 per share. This investment, totaling roughly $399,998, comes at a time when the company's shares have faced recent headwinds, having fallen 14.3% over the course of the last week. As of the reporting period, shares were trading at $48.45.



Key Market Drivers and Observations

  • Insider Positioning: The purchase by the CFO follows a period of share price weakness. Analysis suggests that the stock may be trading below its fair value, which could provide a rationale for the executive's decision to buy.
  • Dividend Consistency: Sonoco maintains a dividend yield of 4.4% and has demonstrated a long-term commitment to shareholders by raising its dividend for 43 consecutive years.
  • Analyst Sentiment: Despite recent price adjustments, BofA Securities continues to maintain a Buy rating on the stock. Although they lowered their price target from $67 to $65, they view the company as an attractive risk/reward opportunity, specifically citing potential margin improvements within the paperboard segment.


Financial Performance and Sector Context

The timing of this insider activity follows Sonoco's first-quarter 2026 earnings report. While the company reported earnings per share (EPS) of $1.20, which aligned with analyst expectations, other metrics showed divergence. Specifically, revenue reached $1.68 billion, failing to meet the projected $1.71 billion. This gap between actual and expected revenue has prompted discussions regarding operational execution within the company's business segments.



Risks and Uncertainties

Investors monitoring Sonoco Products Co should consider several specific factors that could impact market performance:

  • Revenue Shortfalls: The recent miss on quarterly revenue compared to analyst forecasts may indicate broader operational challenges that could affect future growth trajectories.
  • Price Target Revisions: While analysts maintain positive ratings, the downward revision of price targets by BofA Securities reflects a recalibration of valuation expectations.
  • Market Volatility: The 14.3% decline in share value over a single week highlights the volatility that can affect consumer and industrial packaging stocks in fluctuating economic environments.

Risks

  • Revenue miss: Q1 2026 revenue of $1.68 billion fell short of the $1.71 billion forecast.
  • Operational concerns: The revenue shortfall has led to investor apprehension regarding operational challenges.
  • Valuation adjustments: Analysts have lowered price targets, suggesting a shift in expected returns.

More from Insider Trading

Arista Networks Chairperson Jayshree Ullal Executes $75.9 Million Stock Sale Apr 24, 2026 Adaptive Biotechnologies COO Executes $798,000 Stock Sale Under Rule 10b5-1 Plan Apr 24, 2026 Insider Activity Alert: Mark E. Strome Affiliate Acquires $200,000 in Zivo Bioscience Shares Apr 24, 2026 RA Capital Healthcare Fund Divests Over 165,000 Vor Biopharma Shares Apr 24, 2026 Neonc Technologies Chief Clinical Officer Increases Equity Stake Amidst Recent Market Volatility Apr 24, 2026